Marty Javors

Learn More
The field of biogerontology has made great strides towards understanding the biological processes underlying aging, and the time is ripe to look towards applying this knowledge to the pursuit of aging interventions. Identification of safe, inexpensive, and non-invasive interventions that slow the aging process and promote healthy aging could have a(More)
This article summarizes the proceedings of a workshop presented at the 2000 RSA Meeting in Denver, Colorado. The aim of this workshop was to discuss the basic methodologies, diagnostic performance, and clinical utility of three technologies: carbohydrate-deficient transferrin, the "Early Detection of Alcohol Consumption" score, and whole blood associated(More)
Rapamycin has been shown to extend lifespan in rodent models, but the effects on metabolic health and function have been widely debated in both clinical and translational trials. Prior to rapamycin being used as a treatment to extend both lifespan and healthspan in the human population, it is vital to assess the side effects of the treatment on metabolic(More)
This report is the first description of dosing procedures, pharmacokinetics, biochemical action, and general tolerability of the antiaging drug rapamycin in the common marmoset, a small and short-lived monkey. Eudragit-encapsulated rapamycin was given orally to trained marmosets in a short-term (3 weeks) and a long-term (14 months) study. Circulating trough(More)
Friedrich M. Wurst, Boris Tabakoff, Christer Alling, Steina Aradottir, Gerhard A. Wiesbeck, Franz Müller-Spahn, Fritz Pragst, Bankole Johnson, Marty Javors, Nassima Ait-Daoud, Gregory E. Skipper, Claudia Spies, Yvonne Nachbar, Otto Lesch, Katrin Ramskogler, Susanne Hartmann, Manfred Wolfersdorf, Sebastian Dresen, Wolfgang Weinmann, Lisa Hines, Alan Kaiser,(More)
  • 1